- Posted September 12, 2011
- Tweet This | Share on Facebook
Chinese firms on U.S. exchanges face fraud charges
By Claude Solnik
The Daily Record Newswire
After dozens of companies based in China went public in the United States over the past five years, regulators are uncovering fraud at some, cooling down what has become a hot sector of the stock market.
Since March, more than 24 Chinese-based firms disclosed accounting problems or auditor resignations.
This has increased Securities and Exchange Commission scrutiny and at least temporarily slowed the pace of Chinese firms going public here.
"I don't want to say it stopped 100 percent," said David Bukzin, a partner at Marcum Bernstein and Pinchuk. "With all the accounting fraud, proven and alleged, combined with skittish investors, it shut it down pretty much."
U.S. exchanges play host to at least 175 firms based in the People's Republic of China, more firms than any other nation outside the United States, followed by 145 from Canada and only 17 from Japan and Mexico, according to the Nasdaq.
But in a rush to go public, regulators are finding that some companies filed financials that were flawed or fraudulent.
Problems surfaced as Chinese firms went public through reverse mergers, buying listings instead of undergoing initial public offerings.
"In the last year, there's been a significant amount of fraud uncovered in some of these Chinese companies for overstating volume and profits," said Bruce Madnick, managing partner at Friedman with Long Island offices in Uniondale.
"There's been more scrutiny lately, especially related to these companies that do reverse mergers."
Published: Mon, Sep 12, 2011
headlines Washtenaw County
headlines National
- Techshow attendees dig deeper into AI uses and capabilities
- ACLU and BigLaw firm use ‘Orange is the New Black’ in hashtag effort to promote NY jail reform
- Where can 1Ls get five-figure signing bonuses?
- Law firms see more cyberattacks, ransomware threats, new report says
- BigLaw’s share of litigation funding dropped in 2025
- Woman faces murder charge after allegedly taking abortion medication




